Fresenius Kabi USA LLC is the U.S. unit of a global biopharmaceutical company that makes injectable drugs, infusion therapies, and clinical nutrition products. Its filings show it lobbies mainly on health care issues like Medicare and Medicaid payment rules, biosimilar and drug-competition laws, drug shortages, and boosting domestic manufacturing. The company reported about $1.9 million in lobbying across five filings through January 20, 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr STEVEN CHASE WALKER
The latest disclosures for this client.
FRESENIUS KABI USA LLC
1AFRESENIUS KABI USA LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
FRESENIUS KABI USA LLC
SARAH CHRISTINE D'ORSIE
FRESENIUS KABI USA LLC
CRAIG BURTON
FRESENIUS KABI USA LLC
mr CHRISTOPHER LEIBUNDGUTH
FRESENIUS KABI USA LLC
STU EVENHAUGEN
FRESENIUS KABI USA LLC
TIMOTHY CASEY
FRESENIUS KABI USA LLC
CHRIS LEIBUNDGUTH
FRESENIUS KABI USA LLC
FRESENIUS KABI USA LLC
Q4FRESENIUS KABI USA LLC
3AFRESENIUS KABI USA LLC
Q3FRESENIUS KABI USA LLC
Q2FRESENIUS KABI USA LLC
Q1